p53 mutation in a case of blastic transformation of follicular lymphoma with double bcl-2 rearrangement (MBR AND VCR)

被引:13
作者
Nomdedéu, JF [1 ]
Baiget, M [1 ]
Gaidano, G [1 ]
Estivill, C [1 ]
Lasa, A [1 ]
Rubiol, E [1 ]
Mateu, R [1 ]
Bordes, R [1 ]
Brunet, S [1 ]
Saglio, G [1 ]
Soler, J [1 ]
机构
[1] Hosp Santa Creu & Sant Pau, Dept Hematol, Barcelona, Spain
关键词
bcl-2; gene; non-Hodgkin's lymphoma; p53; mutation; molecular genetics;
D O I
10.3109/10428199809050919
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The bcl-2 gene is rearranged in most cases of follicular lymphoma and the breakpoint clusters are found in two specific regions: mbr and mcr. Rearrangements of the immunoglobulin heavy chain genes (IgH) result in a deregulation of the gene and increased transcription of mRNA for the bcl-2 protein. In cases of rearrangement of the light chains (variant translocations), a third breakpoint has been described at the 5' part of the bcl-2 locus (Vcr). In the present case, we report the molecular analysis of an FL transformed into a blastic phase unresponsive to chemotherapy. Molecular studies revealed a typical bcl-2 rearrangement at the major locus (mbr). Ver rearrangements was also observed with only a single restriction enzyme. At the same time, SSCP analysis of exon 5 of the p53 locus disclosed an abnormal conformer. Direct sequencing revealed a point mutation at codon 163 (A --> G). Immunohistochemical analysis of the affected sites disclosed overexpression of p53 and bcl-2. It is concluded that p53 mutation can contribute to blastic transformation in cases of follicular lymphomas with double rearrangement at the bcl-2 locus (mbr/vcr).
引用
收藏
页码:595 / +
页数:14
相关论文
共 37 条
[1]   VARIANT TRANSLOCATION OF THE BCL-2 GENE TO IMMUNOGLOBULIN-LAMBDA LIGHT CHAIN GENE IN CHRONIC LYMPHOCYTIC-LEUKEMIA [J].
ADACHI, M ;
COSSMAN, J ;
LONGO, D ;
CROCE, CM ;
TSUJIMOTO, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (08) :2771-2774
[2]  
BALDINI L, 1994, BLOOD, V84, P270
[3]  
BEISHUIZEN A, 1994, LEUKEMIA, V8, P2228
[4]  
BHATIA K, 1994, BLOOD, V84, P883
[5]   POINT MUTATIONS IN THE C-MYC TRANSACTIVATION DOMAIN ARE COMMON IN BURKITTS-LYMPHOMA AND MOUSE PLASMACYTOMAS [J].
BHATIA, K ;
HUPPI, K ;
SPANGLER, G ;
SIWARSKI, D ;
IYER, R ;
MAGRATH, I .
NATURE GENETICS, 1993, 5 (01) :56-61
[6]  
CLARK HM, 1994, CANCER RES, V54, P3383
[7]   DETECTION OF A 2ND T(14-18) BREAKPOINT CLUSTER REGION IN HUMAN FOLLICULAR LYMPHOMAS [J].
CLEARY, ML ;
GALILI, N ;
SKLAR, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 164 (01) :315-320
[9]   Richter's syndrome in a case of atypical chronic lymphocytic leukaemia with the t(11;14)(q13;q32): Role for a p53 exon 7 gene mutation [J].
Cuneo, A ;
DeAngeli, C ;
Roberti, MG ;
Piva, N ;
Bigoni, R ;
Gandini, D ;
Rigolin, GM ;
Moretti, S ;
Cavazzini, P ;
DelSenno, L ;
Castoldi, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (02) :375-381
[10]  
DeVries EMG, 1996, HUM MUTAT, V7, P202, DOI 10.1002/(SICI)1098-1004(1996)7:3<202::AID-HUMU4>3.0.CO